Phase 1 Study of PK and Safety of HM15912 (Sonefpeglutide) in Subjects With Normal and Severe Kidney Function
Clinical trial NCT05711381 · COMPLETED
Trial details
- NCT number
- NCT05711381
- Sponsor
- Hanmi Pharmaceutical Company Limited
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-02
- Primary completion
- 2023-08-15
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.